Feed NGVT
NG

Ingevity

NGVT · NYSE

$72.35 +1.77% (+$1.26)
1M +2.65%
Market Cap $2.44B
P/E Ratio 45.23x
Div. Yield -
ROE 85.17%

Bulios Fair Price

$55.29

23.6% downside

Current Price

$72.35

Undervalued Fair Value Overvalued

According to Bulios Fair Price, NGVT is currently overvalued relative to its market price. How does it work?

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

Analysis

An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.

Piotroski F-Score Strong
9/9
Valuation
28 /100
Expensive
EV/EBITDA 18.70x
P/S 2.11x
P/B 52.08x
Growth
35 /100
Stable
FCF growth 16.97%
Book val. growth 65.09%
Rev. growth 11.21%
Profitability
91 /100
Strong
Net margin 4.65%
Op. margin 21.61%
FCF margin 13.35%
Quality
83 /100
Excellent
ROE 85.17%
ROA 3.51%
Asset turnover 0.75x
Debt
17 /100
High
Current ratio 1.61x
Int. coverage 1.39x
Net debt/EBITDA 5.95x
Stability
57 /100
Moderate
Rev. volatility 10.60%
EPS volatility 4,492.06%
Profitable years 0

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Ask StockBot about NGVT
Online

About the company

Ingevity Corporation is an American company focused on the production of advanced specialty chemicals and materials used in environmental, automotive, construction, and other industrial applications. The company emphasizes sustainability, innovation, and environmentally friendly technologies that help reduce environmental impacts.

Sector

Basic Materials

Industry

Chemicals - Specialty

CEO

David H. Li

Employees

1,500

Headquarters

North Charleston

Upcoming events

04 NOV

Earnings

Upcoming earnings report

31d

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.